BB

BB Biotech Portfolio holdings

AUM $3.98B
1-Year Est. Return 15.06%
This Quarter Est. Return
1 Year Est. Return
+15.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.55B
AUM Growth
+$396M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
30
New
Increased
Reduced
Closed

Top Buys

1
+$41.3M
2
+$8.01M
3
+$6.72M
4
TSRO
TESARO, Inc.
TSRO
+$3.92M
5
AGIO icon
Agios Pharmaceuticals
AGIO
+$3.25M

Top Sells

1
+$11.2M
2
+$7.06M
3
+$6.5M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$3.15M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$2.83M

Sector Composition

1 Healthcare 86.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$432M 12.18%
3,609,298
+20,000
2
$407M 11.46%
3,750,406
3
$404M 11.39%
6,529,838
-105,000
4
$281M 7.91%
2,774,596
5
$263M 7.41%
4,272,140
6
$197M 5.56%
1,034,428
7
$177M 4.97%
3,121,552
-50,000
8
$172M 4.84%
1,365,445
9
$140M 3.95%
2,159,921
+50,000
10
$125M 3.51%
2,581,112
11
$122M 3.43%
7,029,832
+100,000
12
$111M 3.13%
205,000
13
$107M 3%
1,132,499
14
$69.9M 1.97%
416,500
15
$64.3M 1.81%
1,229,582
+75,000
16
$62M 1.75%
1,991,900
+100,000
17
$57.4M 1.62%
1,305,000
18
$49.9M 1.41%
1,510,150
19
$46.2M 1.3%
750,000
20
$42.2M 1.19%
1,302,912
21
$41.3M 1.16%
+708,663
22
$38.2M 1.08%
255,719
+45,000
23
$33.9M 0.95%
431,991
-90,000
24
$21.8M 0.61%
320,000
25
$21.2M 0.6%
2,700,737
1
2